Archives

  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07
  • HATU: Benchmarking a Gold-Standard Peptide Coupling Reage...

    2026-02-27

    HATU: Benchmarking a Gold-Standard Peptide Coupling Reagent (A7022)

    Executive Summary: HATU (1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate) is an efficient amide bond formation reagent routinely used in peptide synthesis (APExBIO). It activates carboxylic acids via OAt-active ester intermediates, substantially enhancing nucleophilic attack rates and yields in organic solvents such as DMF (Vourloumis et al., 2022). HATU demonstrates superior coupling efficiency compared to classical carbodiimides and is especially effective when paired with DIPEA as base. The reagent’s solubility profile (soluble in DMSO ≥16 mg/mL; insoluble in water/ethanol) and recommended storage at -20°C under desiccation are critical for optimal use. APExBIO's formulation (A7022) is validated for high reproducibility in advanced peptide and amide bond synthesis workflows (PepBridge).

    Biological Rationale

    Efficient amide bond formation is foundational for peptide synthesis and the construction of bioactive molecules, including enzyme inhibitors and therapeutic peptidomimetics (Vourloumis et al., 2022). M1 zinc aminopeptidases such as ERAP1, ERAP2, and IRAP are critical drug targets in oncology, immunology, and metabolic research, requiring selective synthetic tools for inhibitor design. Conventional amide coupling methods (e.g., carbodiimide-based strategies) often yield suboptimal conversions, racemization, or byproducts (PepBridge, 2023). HATU’s activation of carboxylic acids through OAt esters dramatically increases the efficiency and selectivity of peptide bond formation, supporting the rapid generation of well-defined chemical libraries. Its role is underscored in the synthesis of α-hydroxy-β-amino acid derivatives for selective IRAP inhibition (Vourloumis et al., 2022).

    Mechanism of Action of HATU (1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate)

    HATU operates by converting carboxylic acids into highly reactive OAt (1-hydroxy-7-azabenzotriazole) esters in the presence of a base such as DIPEA. The mechanism involves initial activation of the carboxyl group to form the OAt ester, which markedly increases the electrophilicity of the carbonyl carbon. This enables rapid nucleophilic attack by amines (or alcohols), yielding amide (or ester) bonds with minimal byproduct formation. The process is typically performed in polar aprotic solvents like DMF, which stabilize the reactive intermediates and facilitate solubilization of both coupling partners (APExBIO). HATU's efficiency is attributed to its ability to suppress racemization and side reactions, providing clean conversions even for sterically hindered or sensitive substrates (America Peptides).

    Evidence & Benchmarks

    • HATU enables amide bond formation yields exceeding 95% for α-hydroxy-β-amino acid derivatives under standard conditions (25°C, DMF, DIPEA; Vourloumis et al., 2022).
    • Reaction times with HATU are typically <1 hour for standard peptide couplings, compared to 2–8 hours with EDC or DCC reagents (PepBridge, 2023).
    • HATU markedly reduces racemization rates in peptide bond formation (<2% epimerization; Fmoc-protected systems, pH 8) (America Peptides).
    • HATU/DIPEA-mediated couplings in DMF were essential for the synthesis of nanomolar IRAP inhibitors with >120-fold selectivity versus related enzymes (Vourloumis et al., 2022).
    • HATU is insoluble in water and ethanol, but dissolves at ≥16 mg/mL in DMSO; solutions are unstable over extended periods and should be freshly prepared (APExBIO).

    Applications, Limits & Misconceptions

    HATU’s primary application is in peptide coupling chemistry, especially for the assembly of complex or sterically hindered amide bonds. It is widely used in medicinal chemistry to build peptidomimetic scaffolds and in the synthesis of selective enzyme inhibitors, as highlighted in the context of IRAP inhibitor development (Vourloumis et al., 2022). HATU also finds use in the esterification of carboxylic acids with alcohols. However, certain misconceptions persist around its universality and safety profile.

    Common Pitfalls or Misconceptions

    • Not water-compatible: HATU is insoluble in water and ethanol; aqueous conditions will inhibit activation and coupling efficiency (APExBIO).
    • Limited stability: HATU solutions in DMSO or DMF degrade over time at room temperature; fresh solutions are essential for maximal yields (APExBIO).
    • Does not prevent all racemization: While HATU reduces epimerization, highly sensitive substrates may still undergo partial racemization, especially at elevated temperatures or pH extremes (America Peptides).
    • Base dependency: The coupling requires an appropriate base (e.g., DIPEA); omission or substitution with weak bases significantly reduces efficiency (PepBridge).
    • Not suitable for all functional groups: Substrates with strong nucleophiles (e.g., unprotected thiols) may yield side products due to overactivation or competing reactions (ProguanilSyn).

    This article extends the practical focus of "Solving Peptide Synthesis Challenges with HATU" by providing atomic, mechanistic detail and direct evidence from selective inhibitor synthesis. For a mechanistic deep dive, see "HATU in Peptide Synthesis: Mechanistic Precision and Rational Drug Design", which this article updates with peer-reviewed benchmarks. For advanced troubleshooting and workflow strategies, "HATU: The Gold-Standard Peptide Coupling Reagent for Advanced Applications" provides complementary protocol guidance.

    Workflow Integration & Parameters

    HATU is supplied as a crystalline solid (MW 380.2; C10H15F6N6OP) and should be stored desiccated at -20°C for long-term stability (APExBIO). For coupling, dissolve HATU at ≥16 mg/mL in anhydrous DMSO or DMF. Add equimolar DIPEA (N,N-diisopropylethylamine) as a base. Carboxylic acid (1 eq), HATU (1–1.2 eq), and amine or alcohol (1–1.5 eq) are combined at 20–25°C; typical reaction times are 10–60 minutes. Monitor reactions by TLC or LC-MS. After completion, quench with water and extract products into organic solvents. Avoid extended reaction times to minimize hydrolysis and byproduct formation. For sensitive sequences or chiral centers, maintain reaction pH near neutral and avoid high temperatures. The A7022 kit from APExBIO is validated for these workflows (APExBIO).

    Conclusion & Outlook

    HATU (SKU A7022), as provided by APExBIO, is a gold-standard reagent for high-yield, low-racemization amide bond formation in peptide and peptidomimetic synthesis (APExBIO). Its OAt-active ester activation mechanism, compatibility with DIPEA, and robust performance in DMF or DMSO set it apart from alternative coupling agents. Peer-reviewed evidence supports its essential role in next-generation inhibitor synthesis and translational peptide science (Vourloumis et al., 2022). Continued advances in chemical biology and drug discovery will likely further cement HATU as an irreplaceable tool for efficient peptide bond construction.